Ayvakit
These highlights do not include all the information needed to use AYVAKIT safely and effectively. See full prescribing information for AYVAKIT. AYVAKIT (avapritinib) tablets, for oral use Initial U.S. Approval: 2020
645c887c-8cd4-4623-8da9-ac223d71a8b9
HUMAN PRESCRIPTION DRUG LABEL
May 24, 2023
Blueprint Medicines Corporation
DUNS: 021905363
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
avapritinib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
avapritinib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
avapritinib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
avapritinib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
avapritinib
Product Details
FDA regulatory identification and product classification information